The PBTC is a multidisciplinary cooperative researh organization devoted to the study of correlative tumor biology and new therapies for primary CNS tumors of childhood. The National Cancer Institute established and funded a nine-institution Pediatric Brain Tumor Consortium (PBTC). Each participating member institution was selected by competitive review by a NCI special study section based on their extensive experience with pediatric brain tumor clinical trials and ability to support novel correlative studies.
Creador(es): Baylor College of Medicine, Children`s Hospital of Philadelphia,, Children`s Hospital National Medical Center, Duke University, Harvard University, National Cancer Institute, North American Brain Tumor Coalition, St. Jude Children`s Research Hospital, The University of California at San Francisco, University of Pittsburgh, The University of Washington.
Recursos añadido en:
07/10/2002
Objetivo:
The primary objective of the PBTC is to rapidly conduct novel phase I and II clinical evaluations of new therapeutic drugs, intrathecal agents, delivery technologies, biological therapies, and radiation treatment strategies in children age 0 - 21 years of age with primary CNS tumors.
Idiomas disponibles:
Inglés
